glp-1 heart failure medications are not just for weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major GLP-1 receptor agonists (GLP-1RAs): cardiovascular

Medication Is a Tool, Not the Entire Maintenance Plan GLP-1 medications can be powerful tools, but they should not replace the foundations of long-term metabolic care

I don't need substance to enjoy it

The metabolic benefits are compounding, since tirzepatide already boosts metabolism , and quitting smoking further improves cardiovascular and metabolic health

The study, which ended prematurely due to a higher mortality rate in the intensive treatment group, failed to report significant reduction in major cardiovascular events, giving a notion that intensive therapy was associated with significant harm in high risk patients [6]